Cord Blood Stem Cells Market 2017-2022 - A Global Market Overview 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Cord Blood Stem Cells - A Global Market Overview 2018" report has been added to ResearchAndMarkets.com's offering.

The North American market for Cord Blood Stem Cells overpowers with a commanding share of around 38%, equivalent to some US$22.1 billion in 2017 and continues to grow with more technological advancement in the next five years as well owing the demand for stem cell therapies and research.

Asia-Pacific market is expected to grow at an elevated CAGR of over 30% for forecasting period of 2017-2022, although it holds a nominal share currently in the global market. The vast growth can be attributed to various factors such as health care reforms, ease of government regulatory, awareness of stem cell banking in countries like Malaysia, Indonesia, China, India and others.

Key Market Trends

  • Private Cord Blood Banks to Remain Most Preferred Storage Option
  • Stem Cells Therapy - A Potential Game Changer in Disease Treatment'
  • Human Umbilical Cord Blood Cell Transplantation in Neuro-regenerative Strategies
  • Cord Blood Stem Cells role in Cardiovascular Diseases
  • Umbilical Cord Blood Gives New Hope in Autism Spectrum Disorder (ASD)
  • Excellent Practices in India
  • Asia Pacific Projected for Most Impressive Growth Rate

Research Findings & Coverage

  • The global market for Cord Blood Stem Cells is analyzed in this report with respect to key and major application areas
  • Private Cord Blood Banks to Remain Most Preferred Storage Option
  • Stem Cells Therapy - A Potential Game Changer in Disease Treatment'
  • Umbilical Cord Blood Gives New Hope in Autism Spectrum Disorder (ASD)
  • Asia-Pacific Projected for Most Impressive Growth Rate
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 64
  • The industry guide includes the contact details for 412 private and public cord blood banks

Product Outline

The report analyzes the market for technologies of Cord Blood Stem Cells including:

  • Stem Cell Transplant
  • Cord Blood Banking
  • Blood Transfusion
  • Cell Based Genetics
  • Xenotransplant

Application areas of Cord Blood Stem Cells analyzed comprise the following:

  • Cancer
  • Blood disorders
  • Metabolic Disorders
  • Immune Disorders
  • Osteopetrosis
  • Other Applications

Analysis Period & Units

  • The report reviews, analyzes and projects the global Cord Blood Stem Cells market for the period 2014-2022 in terms of US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2022.

Key Topics Covered:

Part A: Global Market Perspective

1. Introduction

2. Key Market Trends

3. Key Global Players

4. Key Business & Product Trends

5. Global Market Overview

Part B: Regional Market Perspective

Regional Market Overview

1. North America

2. Europe

3. Asia-Pacific

4. Rest of World

Part C: Guide to the Industry

1. Public Cord Blood Banks

2. Private Cord Blood Banks

Part D: Annexure

Companies Mentioned

  • AMAG Pharmaceuticals
  • AVIC Biology Enter
  • Alphacord LLC
  • Americord Registry LLC
  • Anthony Nolan
  • Athersys, Inc.
  • Babycord Jordan
  • Carolinas Cord Blood Bank
  • Celgene Cellular Therapeutics
  • Cell Care Pty Ltd
  • Cord Blood America, Inc.
  • Cord Blood Solutions, Inc.
  • Cordbank New Zealand
  • Cordlife Group Limited
  • Coriell Institute
  • Coriell Institute for Medical Research
  • Golden Meditech Holdings Limited
  • International Stemcell Services Ltd.
  • Lifebankusa Inc.
  • Lifecell International Private Limited
  • Lifecord
  • Lifeforce Cryobanks
  • MD Anderson
  • MTI-GlobalStem
  • Mesoblast Limited
  • Nanjing Xinjiekou
  • New England Cord Blood Bank, Inc.
  • New York Blood Center
  • Procrea
  • Reneuron Group Plc
  • VITA 34 AG
  • ViaCell, Inc.
  • ViaCord, Inc.
  • Vita 34 AG
  • Women's Health Dexeus

For more information about this report visit https://www.researchandmarkets.com/research/jjbjdn/cord_blood_stem?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells